Evidence map›Paper›PMID 32823397›Full record

ReviewIndian journal of ophthalmology2020

Ocular tuberculosis: Where are we today?

Ilaria Testi, Rupesh Agrawal, Salil Mehta, Soumvaya Basu, Quan Nguyen, Carlos Pavesio, Vishali Gupta

Abstract readReview
In one paragraph

Review in Indian journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Primary tubercular chorioretinitis: A case report.The Journal of international medical research · 2026
    Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Presumed Ocular tuberculosis masquerading as autoimmune retinopathy.American journal of ophthalmology case reports · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Clinical manifestation and long-term follow-up of presumed ocular tuberculosis in China.Journal of clinical tuberculosis and other mycobacterial diseases · 2024
    Article
  15. Article
  16. The Neuro-Ophthalmology of Tuberculosis.Neuro-ophthalmology (Aeolus Press) · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ilaria TestiMoorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
Rupesh AgrawalMoorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom; National Healthcare Group Eye Institute, Tan Tock Seng Hospital; Singapore Eye Research Institute, Singapore.
Salil MehtaDepartment of Ophthalmology, Lilavati Hospital and Research Center, Mumbai, India.
Soumvaya BasuLV Prasad Eye Institute, Bhubaneswar, India.
Quan NguyenByres Eye Institute, Stanford University, Palo Alto, California, USA.
Carlos PavesioMoorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
Vishali GuptaAdvanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosis and management of ocular tuberculosis (OTB) poses a significant challenge. Mixed ocular tissue involvement and lack of agreement on best practice diagnostic tests together with the global variations in therapeutic management contributed to the existing uncertainties regarding the outcome of the disease. The current review aims to update recent progress on OTB. In particular, the Collaborative Ocular Tuberculosis Study (COTS) group recently standardized a nomenclature system for defining clinical phenotypes, and also proposed consensus guidelines and an algorithmic approach for management of different clinical phenotypes of OTB. Recent developments in experimental research and innovations in molecular diagnostics and imaging technology have provided a new understanding in the pathogenesis and natural history of the disease.

Indexed as

Tuberculosis, OcularAntitubercular AgentsConsensusHumansAntitubercular AgentsAntitubercular therapycollaborative ocular tuberculosis study (COTS)COTS CON nomenclatureetiopathogenesismultimodal imagingocular tuberculosistubercular uveitis

Identifiers

PMID32823397
PMCPMC7690544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.